|
EIF1AD expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.60380003616712E-09 |
| Normal-vs-Stage2 |
7.83350000421734E-08 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
7.60800000000339E-05 |
| Stage1-vs-Stage2 |
6.427400E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
8.999000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
7.138800E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6269208202857E-12 |
| Normal-vs-AfricanAmerican |
1.99899999997477E-07 |
| Normal-vs-Asian |
5.01719999990158E-08 |
| Caucasian-vs-AfricanAmerican |
2.154400E-02 |
| Caucasian-vs-Asian |
1.062030E-01 |
| AfricanAmerican-vs-Asian |
2.477400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.3694999991325E-08 |
| Normal-vs-Female |
1.73516756518666E-12 |
| Male-vs-Female |
8.531500E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.23510000000915E-05 |
| Normal-vs-Extreme_Weight |
1.32980000344673E-08 |
| Normal-vs-Obese |
1.7089299999995E-05 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
6.570800E-01 |
| Normal_Weight-vs-Obese |
2.940000E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
4.838800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6407899999904E-05 |
| Normal-vs-Age(41-60Yrs) |
1.76434999999975E-05 |
| Normal-vs-Age(61-80Yrs) |
1.73627778821128E-12 |
| Normal-vs-Age(81-100Yrs) |
1.759430E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.365400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.822800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.926610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.280600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.150000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.401700E-02 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
5.927200E-01 |
| Normal-vs-Grade 3 |
9.738600E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
3.189800E-01 |
| Grade 2-vs-Grade 4 |
5.927200E-01 |
| Grade 3-vs-Grade 4 |
9.738600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.73214784130005E-12 |
| Normal-vs-N1 |
1.30470079184875E-11 |
| N0-vs-N1 |
3.616400E-02 |
|
|
